Kaiser Pfizer Vaccine Trial

The company made the announcement early monday saying.

Kaiser pfizer vaccine trial. Walter isaacson a participant in pfizer s covid vaccine trial describes what it s like. Dusta eisenman volunteered for a phase 3 trial to test a candidate covid 19 vaccine. The department of research evaluation in pasadena california. The investigational vaccine being tested in this trial is bnt162b2 one of the vaccine candidates in development by pfizer inc.

The vaccine in early trials had. And the division of. Published mon nov 9 2020 11 28 am est updated mon nov 9 2020 12 02 pm est. The clinical trial is being conducted by investigators at the kaiser permanente center for health research in portland oregon.

The phase 3 clinical trial will test the vaccine in 1 400 adults at sites in california and oregon. Pfizer inc s pfe n experimental covid 19 vaccine is more than 90 effective based on initial trial results the drugmaker said on monday a major victory in the war against a virus that has. The trial is assessing how. Pfizer and the german biotech company biontech said on monday that they had had encouraging early results from a phase 3 clinical trial of their coronavirus vaccine.

And biontech which are also the sponsors of the study. Pfizer s candidate vaccine he said. Today kaiser permanente began participating in a phase 3 clinical trial to test an investigational vaccine against sars cov 2 the virus causing the current covid 19 global pandemic kaiser permanente plans to enroll approximately 1 400 participants at 4 sites in california. Kaiser permanente is part of a worldwide study of the pfizer vaccine s phase three trial which means its the last stage before results go to the federal government for approval.